Effect of linagliptin monotherapy on glycaemic control and markers of [beta]-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.
Del Prato, S. 1; Barnett, A. H. 2; Huisman, H. 3; Neubacher, D. 4; Woerle, H.-J. 4; Dugi, K. A. 5
Diabetes, Obesity & Metabolism.
13(3):258-267, March 2011.
(Format: HTML, PDF)